Back to Search
Start Over
Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents.
- Source :
- Immunotherapy (1750743X); Jul2019, Vol. 11 Issue 12, p1057-1065, 9p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 1750743X
- Volume :
- 11
- Issue :
- 12
- Database :
- Complementary Index
- Journal :
- Immunotherapy (1750743X)
- Publication Type :
- Academic Journal
- Accession number :
- 138227654
- Full Text :
- https://doi.org/10.2217/imt-2019-0057